Streptozotocin

Overview

Streptozotocin (Streptozocin; STZ) is an antibiotic widely used in experimental animal models of induced diabetes. Streptozotocin enters B cells via the glucose transporter ( GLUT2 ) and causes the alkylation of DNA ( DNA-methylating ). Streptozotocin can induce the apoptosis of β cells.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > DNA Alkylator/Crosslinker | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-13753
• CAS No.: 18883-66-4
• Molecular Formula: C8H15N3O7
• Molecular Weight: 265.22
• Purity: 99.13%
• Storage: -20°C, sealed storage, away from moisture and light * The compound is unstable in solutions, freshly prepared is recommended.
• Solubility: 50 mg/mL (188.52 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source